Natco Pharma Ltd - Share Price
NATCOPHARM
Natco Pharma LtdFinancials
Natco Pharma LtdNews & Updates
Natco Pharma launches epilepsy treatment drug in India
Feb 26,2021 01:03 PM
The drug maker on Friday announced the launch of brivaracetam tablets under brand Brecita in India.
Natco Pharma launches Brivaracetam tablets under brand BRECITA in India Feb 26,2021
NATCO Pharma launches Brivaracetam tablets for epilepsy treatment in India Feb 26,2021
Board of Natco Pharma recommends Third Interim Dividend Feb 12,2021
Board of Natco Pharma recommends Third Interim Dividend Feb 11,2021
Natco Pharma fixes record date for interim dividend of Re 1 Feb 11,2021
Meeting Type
Meeting Date
Resolution Type | Description Of Resolution | IiAS Recommendation |
---|
Peer Comparison
Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd | 613.40 | 48.85 | 144,991.81 | 555.55 | 0.66 | 3,366.01 | 106.10 |
Divis Laboratories Ltd | 3,519.25 | 49.46 | 91,926.46 | 461.24 | 0.46 | 1,656.48 | 313.47 |
Dr Reddys Laboratories Ltd | 4,408.75 | 31.15 | 74,057.63 | 443.70 | 0.56 | 3,397.50 | 979.38 |
Cipla Ltd | 812.30 | 23.94 | 63,670.05 | 698.93 | 0.51 | 3,689.88 | 233.61 |
Aurobindo Pharma Ltd | 883.80 | 17.16 | 51,164.16 | 740.51 | 0.34 | 3,701.14 | 246.88 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Natco Pharma LtdSummary & Reports
No Company Summary found
Registered Office
Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033
Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in
Registrar Office
12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA
Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com
Reports by natco-pharma-ltd-share-price
Latest Release by natco-pharma-ltd-share-price
Result Express
Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates
Mar 02, 2021 03:25 PM
The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.
Shareholding Snapshot
Corporate Action
Purpose
Dividend
Annc. Date
11 Feb 2021
Effective. Date
22 Feb 2021
Divi. Type
Interim 3
Divi.(%)
50
Divi. Amt.
1
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More
Purpose
Board Meeting
Exp. Date
11 Feb 2021
Annc. Date
03 Feb 2021
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More
Purpose
Dividend
Annc. Date
12 Nov 2020
Effective. Date
24 Nov 2020
Divi. Type
Interim 2
Divi.(%)
150
Divi. Amt.
3
Unaudited Financial Results for the Quarter and Half year ended 30th September, 2020... More